Template:Pharmacomodulation: Difference between revisions
Content deleted Content added
m Bot: links syntax |
m Disambiguating links to Serotonergic (link changed to Serotonin) using DisamAssist. |
||
| (36 intermediate revisions by 21 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox |
{{Navbox |
||
| name = Pharmacomodulation |
|||
| title = [[Pharmacology|Pharmacomodulation]] |
|||
| name = Neuromodulation |
|||
| state = {{{state<includeonly>|collapsed</includeonly>}}} |
|||
| title = [[Neuromodulation]] |
|||
| listclass = hlist |
|||
| group1 = Types |
| group1 = Types |
||
| list1 = |
| list1 = |
||
* [[Enzyme]]: [[Enzyme inducer|Inducer]] |
* ♦ [[Enzyme]]: [[Enzyme inducer|Inducer]] |
||
* [[Enzyme inhibitor|Inhibitor]] |
|||
* [[Ion channel]]: [[Channel opener|Opener]]{{•}} [[Channel blocker|Blocker]] |
|||
* ♦ [[Ion channel]]: [[Channel opener|Opener]] |
|||
* [[Receptor (biochemistry)|Receptor]]: [[Receptor agonist|Agonist]]{{•}} [[Receptor antagonist|Antagonist]]{{•}} [[Positive allosteric modulator]] (PAM){{•}} [[Negative allosteric modulator]] (NAM){{•}} [[Inverse agonist]] |
|||
* [[Channel blocker|Blocker]] |
|||
* [[Membrane transport protein|Transporter]] <nowiki>[</nowiki>[[Reuptake]]<nowiki>]</nowiki>: [[Reuptake enhancer|Enhancer]] (RE){{•}} [[Reuptake inhibitor|Inhibitor]] (RI){{•}} [[Releasing agent|Releaser]] (RA) |
|||
* Miscellaneous: [[Precursor (chemistry)|Precursor]]{{•}} [[Cofactor (biochemistry)|Cofactor]] |
|||
* ♦ [[Receptor (biochemistry)|Receptor]]: [[Agonist]] |
|||
* [[Partial agonist]] |
|||
* [[Receptor antagonist|Antagonist]] |
|||
* [[Inverse agonist]] |
|||
* [[Positive allosteric modulator]] (PAM) |
|||
* [[Negative allosteric modulator]] (NAM) |
|||
* ♦ [[Membrane transport protein|Transporter]] <nowiki>[</nowiki>[[Reuptake]] vs [[Reverse transport|Efflux]]<nowiki>]</nowiki>: [[Reuptake enhancer|Enhancer]] (RE) |
|||
* [[Reuptake inhibitor|Inhibitor]] (RI) |
|||
* [[Releasing agent|Releaser]] (RA) |
|||
* ♦ Miscellaneous: [[Precursor (chemistry)|Precursor]] |
|||
* [[Cofactor (biochemistry)|Cofactor]] |
|||
| group2 = Classes |
| group2 = Classes |
||
| list2 = {{Navbox |
| list2 = {{Navbox|subgroup |
||
| group1 = [[Enzyme]] |
| group1 = [[Enzyme]] |
||
| Line 19: | Line 34: | ||
| group2 = [[Ion channel]] |
| group2 = [[Ion channel]] |
||
| list2 = |
|||
| list2 = [[Calcium channel blocker]] (CCB){{•}} [[Potassium channel blocker]] (PCB){{•}} [[Sodium channel blocker]] (SCB){{•}} [[Potassium channel opener]] (PCO) |
|||
See [[template:channel blockers|Ion channel modulators]] |
|||
| group3 = [[Receptor (biochemistry)|Receptor]] &<br/>[[Membrane transport protein|transporter]] |
| group3 = [[Receptor (biochemistry)|Receptor]] &<br/>[[Membrane transport protein|transporter]] |
||
| list3 = {{Navbox |
| list3 = {{Navbox|subgroup |
||
| group1 = [[Biogenic amine|BA]]/[[Monoamine neurotransmitter|M]] |
|||
| list1 = {{Navbox|subgroup |
|||
| group1 = [[Adrenergic]] |
| group1 = [[Adrenergic]] |
||
| list1 = |
|||
| list1 = [[Adrenergic agonist|Adrenergic receptor agonist]] ([[Alpha-adrenergic agonist|α]], [[Beta-adrenergic agonist|β]] ([[Beta1-adrenergic agonist|1]], [[Beta2-adrenergic agonist|2]])){{•}} [[Adrenergic antagonist|Adrenergic receptor antagonist]] ([[Alpha blocker|α]] ([[Alpha-1 blocker|1]], [[Alpha-2 blocker|2]]), [[Beta blocker|β]]){{•}} [[Adrenergic reuptake inhibitor]] (ARI) |
|||
* [[Adrenergic agonist|Adrenergic receptor agonist]] ([[Alpha-adrenergic agonist|α]] |
|||
* [[Beta-adrenergic agonist|β]] ([[Beta1-adrenergic agonist|1]] |
|||
| group2 = [[Cholinergic]] |
|||
* [[Beta2-adrenergic agonist|2]])) |
|||
| list2 = [[Acetylcholine agonist|Acetylcholine receptor agonist]] ([[Muscarinic agonist|Muscarinic]], [[Nicotinic agonist|Nicotinic]]){{•}} [[Acetylcholine antagonist|Acetylcholine receptor antagonist]] ([[Muscarinic antagonist|Muscarinic]], [[Nicotinic antagonist|Nicotinic]] ([[Ganglionic blocker|Ganglionic]], [[Neuromuscular blocker|Muscular]])) |
|||
* [[Adrenergic antagonist|Adrenergic receptor antagonist]] ([[Alpha blocker|α]] ([[Alpha-1 blocker|1]] |
|||
* [[Alpha-2 blocker|2]]) |
|||
* [[Beta blocker|β]]) |
|||
* [[Norepinephrine reuptake inhibitor]] (NRI) |
|||
| group3 = [[Dopaminergic]] |
| group3 = [[Dopaminergic]] |
||
| list3 = |
|||
| list3 = [[Dopamine agonist|Dopamine receptor agonist]]{{•}} [[Dopamine antagonist|Dopamine receptor antagonist]]{{•}} [[Dopamine reuptake inhibitor]] (DRI) |
|||
* [[Dopamine agonist|Dopamine receptor agonist]] |
|||
* [[Dopamine antagonist|Dopamine receptor antagonist]] |
|||
| group4 = [[Endocannabinoid system|Endocannabinoid]] |
|||
* [[Dopamine reuptake inhibitor]] (DRI) |
|||
| list4 = [[Cannabinoid receptor agonist]]{{•}} [[Cannabinoid receptor antagonist]] |
|||
| group5 = [[Histaminergic]] |
| group5 = [[Histaminergic]] |
||
| list5 = |
|||
| list5 = [[Histamine agonist|Histamine receptor agonist]]{{•}} [[Histamine antagonist|Histamine receptor antagonist]] ([[H1 antagonist|H<sub>1</sub>]], [[H2 antagonist|H<sub>2</sub>]], [[H3 antagonist|H<sub>3</sub>]]) |
|||
* [[Histamine agonist|Histamine receptor agonist]] |
|||
* [[Histamine antagonist|Histamine receptor antagonist]] ([[H1 antagonist|H<sub>1</sub>]] |
|||
* [[H2 antagonist|H<sub>2</sub>]] |
|||
* [[H3 receptor antagonist|H<sub>3</sub>]]) |
|||
| group9 = [[Serotonin|Serotonergic]] |
|||
| list9 = |
|||
* [[Serotonin receptor agonist]] |
|||
* [[Serotonin antagonist|Serotonin receptor antagonist]] ([[5-HT3 antagonist|5-HT<sub>3</sub>]]) |
|||
* [[Serotonin reuptake inhibitor]] (SRI) |
|||
}} |
|||
| group2 = [[Amino acid|AA]] |
|||
| list2 = {{Navbox|subgroup |
|||
| group6 = [[GABAergic]] |
| group6 = [[GABAergic]] |
||
| list6 = [[GABA agonist|GABA receptor agonist]] |
| list6 = |
||
* [[GABA agonist|GABA receptor agonist]] |
|||
* [[GABA antagonist|GABA receptor antagonist]] |
|||
* [[GABA reuptake inhibitor]] (GRI) |
|||
| group7 = [[Glutamatergic]] |
| group7 = [[Glutamatergic]] |
||
| list7 = |
|||
| list7 = [[Excitatory amino acid agonist|Glutamate receptor agonist]] ([[Ampakine|AMPA]]){{•}} [[Excitatory amino acid antagonist|Glutamate receptor antagonist]] ([[NMDA receptor antagonist|NMDA]]) |
|||
* [[Excitatory amino acid agonist|Glutamate receptor agonist]] ([[Ampakine|AMPA]]) |
|||
* [[Excitatory amino acid antagonist|Glutamate receptor antagonist]] ([[NMDA receptor antagonist|NMDA]]) |
|||
* [[Excitatory amino acid reuptake inhibitor|Glutamate reuptake inhibitor]] |
|||
}} |
|||
| group8 = [[Opioid]] |
|||
| list8 = [[Opioid receptor agonist]]{{•}} [[Opioid receptor antagonist]] |
|||
| group3 = [[Cholinergic]] |
|||
| list3 = |
|||
* [[Parasympathomimetic_drug|Acetylcholine receptor agonist]] ([[Muscarinic agonist|Muscarinic]] |
|||
* [[Nicotinic agonist|Nicotinic]]) |
|||
**[[Cholinesterase inhibitor]] |
|||
* [[Anticholinergic|Acetylcholine receptor antagonist]] ([[Muscarinic antagonist|Muscarinic]] |
|||
* [[Nicotinic antagonist|Nicotinic]] ([[Ganglionic blocker|Ganglionic]] |
|||
* [[Neuromuscular-blocking drug|Muscular]])) |
|||
| group4 = [[Endocannabinoid system|Cannabinoidergic]] |
|||
| list4 = |
|||
* [[Cannabinoid|Cannabinoid receptor agonist]] |
|||
* [[Cannabinoid receptor antagonist]] |
|||
* [[Endocannabinoid enhancer]] (eCBE) |
|||
* [[Endocannabinoid reuptake inhibitor]] (eCBRI) |
|||
| |
| group8 = [[Opioidergic]] |
||
| list8 = |
|||
| list9 = [[Serotonin receptor agonist]]{{•}} [[Serotonin antagonist|Serotonin Receptor Antagonist]] ([[5-HT3 antagonist|5-HT<sub>3</sub>]]){{•}} [[Serotonin reuptake inhibitor]] (SRI){{•}} [[Serotonin reuptake enhancer]] (SRE) |
|||
* [[Opioid modulator]] |
|||
* [[Opioid|Opioid receptor agonist]] |
|||
* [[Opioid antagonist|Opioid receptor antagonist]] |
|||
* [[Enkephalinase inhibitor]] |
|||
| group10 = Other |
| group10 = Other |
||
| list10 = |
|||
| list10 = [[Adenosine reuptake inhibitor]] (AdoRI){{•}} [[Angiotensin II receptor antagonist]]{{•}} [[Endothelin receptor antagonist]]{{•}} [[NK1 receptor antagonist|NK<sub>1</sub> receptor antagonist]]{{•}} [[Vasopressin receptor antagonist]] |
|||
* [[Adenosine reuptake inhibitor]] (AdoRI) |
|||
* [[Angiotensin II receptor antagonist]] |
|||
* [[Endothelin receptor antagonist]] |
|||
* [[NK1 receptor antagonist|NK<sub>1</sub> receptor antagonist]] |
|||
* [[Vasopressin receptor antagonist]] |
|||
}} |
}} |
||
| group4 = Miscellaneous |
| group4 = Miscellaneous |
||
| list4 = |
|||
| list4 = [[Cofactor_(biochemistry)|Cofactor]] (see ''[[Template:Enzyme cofactors|Enzyme cofactor]]s''){{•}} [[Precursor (chemistry)|Precursor]] (see ''[[Template:Amino acids|Amino acid]]s'') |
|||
* [[Cofactor_(biochemistry)|Cofactor]] (see ''[[Template:Enzyme cofactors|Enzyme cofactor]]s'') |
|||
* [[Precursor (chemistry)|Precursor]] (see ''[[Template:Amino acids|Amino acid]]s'') |
|||
}} |
}} |
||
}}<noinclude> |
|||
}} |
|||
{{Documentation|content= |
|||
<noinclude> |
|||
{{Collapsible option}} |
|||
[[Category:Drug templates|{{PAGENAME}}]] |
|||
[[Category:Drug navigational boxes]] |
|||
</noinclude> |
|||
[[Category:Pharmacology templates]] |
|||
}}</noinclude> |
|||
Latest revision as of 09:52, 23 May 2023
Template documentationThis template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Pharmacomodulation|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Pharmacomodulation|state=expanded}}will show the template expanded, i.e. fully visible.